BlossomHill Therapeutics Funding & Investors
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.
bhtherapeutics.comTotal Amount Raised: $71,000,000
BlossomHill Therapeutics Funding Rounds
Series A
$71,000,000
Series A Investors
Vivo CapitalCormorant Asset ManagementHercules Bioventure PartnersOrbiMed Advisors
Funding info provided by Diffbot.